These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32306919)

  • 1. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
    Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
    BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
    Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
    J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.
    Yu C; Skootsky S; Grossman M; Garner OB; Betlachin A; Esrailian E; Hommes DW; May FP
    Clin Transl Gastroenterol; 2018 Sep; 9(8):177. PubMed ID: 30177700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized Workflows Improve Colonoscopy Follow-Up After Abnormal Fecal Immunochemical Tests in a Safety-Net System.
    Issaka RB; Rachocki C; Huynh MP; Chen E; Somsouk M
    Dig Dis Sci; 2021 Mar; 66(3):768-774. PubMed ID: 32236885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
    Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
    Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.
    Issaka RB; Bell-Brown A; Snyder C; Atkins DL; Chew L; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    JAMA Netw Open; 2021 Aug; 4(8):e2120159. PubMed ID: 34374771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
    Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
    Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.
    Cusumano VT; Myint A; Corona E; Yang L; Bocek J; Lopez AG; Huang MZ; Raja N; Dermenchyan A; Roh L; Han M; Croymans D; May FP
    Dig Dis Sci; 2021 Nov; 66(11):3760-3768. PubMed ID: 33609211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
    Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
    J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.
    Issaka RB; Bell-Brown A; Kao J; Snyder C; Atkins DL; Chew LD; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    Prev Med Rep; 2022 Aug; 28():101831. PubMed ID: 35637893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening.
    May FP; Yano EM; Provenzale D; Brunner J; Yu C; Phan J; Bharath P; Aby E; Dinh D; Ehrlich DS; Storage TR; Lin LD; Jamaluddin NN; Washington DL
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):469-476. PubMed ID: 29857147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing.
    Cooper GS; Grimes A; Werner J; Cao S; Fu P; Stange KC
    J Am Board Fam Med; 2021; 34(1):61-69. PubMed ID: 33452083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
    Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
    J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer.
    Bowyer HL; Vart G; Kralj-Hans I; Atkin W; Halloran SP; Seaman H; Wardle J; Wagner Cv
    J Med Screen; 2013; 20(3):149-56. PubMed ID: 24045920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients.
    Schneider JL; Rivelli JS; Gruss I; Petrik AF; Nielson CM; Green BB; Coronado GD
    Am J Health Behav; 2020 Jul; 44(4):460-472. PubMed ID: 32553027
    [No Abstract]   [Full Text] [Related]  

  • 19. Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think.
    Luque JS; Wallace K; Blankenship BF; Roos LG; Berger FG; LaPelle NR; Melvin CL
    J Community Health; 2018 Dec; 43(6):1085-1092. PubMed ID: 29767821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.
    San Miguel Y; Demb J; Martinez ME; Gupta S; May FP
    Gastroenterology; 2021 May; 160(6):1997-2005.e3. PubMed ID: 33545140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.